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Abstract
The human and Old World primate genomes possess conserved endogenous retrovirus sequences that have been
implicated in evolution, reproduction, and carcinogenesis. Human endogenous retrovirus (HERV)-K with 5′LTR-gag-
pro-pol-env-rec/np9-3′LTR sequences represents the newest retrovirus family that integrated into the human genome
1 to 5 million years ago. Although a high-level expression of HERV-K in melanomas, breast cancers, and terato-
carcinomas has been demonstrated, the mechanism of the lineage-specific activation of the long terminal repeat
(LTR) remains obscure. We studied chromosomal HERV-K expression in MeWo melanoma cells in comparison with
the basal expression in human embryonic kidney 293 (HEK293) cells. Cloned LTR of HERV-K (HML-2.HOM) was also
characterized by mutation and transactivation experiments. We detected multiple transcriptional initiator (Inr) sites
in the LTR by rapid amplification of complementary DNA ends (5′ RACE). HEK293 and MeWo showed different Inr
usage. The most potent Inr was associated with a TATA box and three binding motifs of microphthalmia-associated
transcription factor (MITF). Both chromosomal HERV-K expression and the cloned LTR function were strongly ac-
tivated in HEK293 by transfection with MITF-M, a melanocyte/melanoma–specific isoform of MITF. Coexpression
of MITF and the HERV-K core antigen was detected in retinal pigmented epithelium by an immunofluorescence
analysis. Although malignant melanoma lines MeWo, G361, and SK-MEL-28 showed enhanced HERV-K transcription
compared with normal melanocytes, the level of MITF-M messenger RNA persisted from normal to transformed
melanocytes. Thus, MITF-M may be a prerequisite for the pigmented cell lineage–specific function of HERV-K LTR,
leading to the high-level expression in malignant melanomas.
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Introduction
The human genome contains 2.7 × 106 retroelements that cover 42%
of the total chromosomal DNA (3 billion nucleotides) [1]. Unlike other
forms of retroelements, endogenous retroviruses (ERVs), which make
up 8% of the present-day human genomic sequences [1], are derived
from archaic infectious retroviruses that integrated into hominids in-
cluding humans and great apes. Human ERVs (HERVs) represent
ERVs prevailing in the human genome [2]. Studies indicated roles of
the envelope protein of HERV-W, syncytin, in placental development
[3,4] and in neuroinflammation [5].
HERV-K represents the newest family of HERVs that was integrated
into the genome approximately 1 to 5 million years ago [6]. HERV-K
proviruses with well-conserved 5′LTR-gag-pro-pol-env-rec/np9-3′LTR
structure, in which LTR signifies the long terminal repeat, exist at 30
to 50 loci on the human chromosomes [1,7,8]. HERV-K types I and
II encode regulatory proteins, Np9 and Rec, respectively, at their 3′
termini, which was expressed through double splicing [9,10]. Rec
and Np9 exert an oncogenic function by interacting with cellular
zinc-finger transcription factors including the promyelocytic leukemia
zinc finger (PLZF) protein [11–13]. Intriguingly, high-level HERV-K
expression was detected in breast cancers, teratocarcinomas, and mela-
nomas [9,14–17]. Very importantly, intensification of HERV-K
expression has been implicated in malignant transformation of melano-
mas [18–20].
HERV-K transcription is enhanced by stepwise incubation with
estradiol and progesterone in breast cancer cells [21,22], although
it remains unclear whether the LTR function is directly controlled
by the nuclear receptors. Involvement of CpG methylation in the
LTR-controlling mechanism was also suggested [23]. A model of
the U3-R-U5 framework of the LTR has been proposed very recently
[24], in which Sp1 and Sp6 were found essential for activation of the
TATA-less promoter. However, the mechanism underlying the cancer-
specific HERV-K expression remains unknown.
On the other hand, microphthalmia-associated transcription factor
(MITF, also termed Mi) is essential for the development of retinal
pigmented epithelium (RPE) and neural crest–derived melanocytes
[25]. In addition to the genes essential for melanin synthesis and
melanosome formation, a number of genes that support cell cycle
progression and survival are induced by MITF [26,27]. MITF,
having a basic helix-loop-helix, leucine-zipper (bHLH-LZ) structure
[28,29], recognizes the E-box, CA(C/T)GTG, as well as the M-box
(TCAYRTG or CAYRTGA) sequences in the promoter/enhancer
region of the target genes, where Y and R represent pyrimidine and
purine, respectively [25,30]. Importantly, theMITF gene (also referred
to as MI, WS2A, bHLHe32) is a proposed lineage-specific oncogene,
based on the gene amplification and its growth-promoting function in
metastatic melanomas [27,31]. Having multiple first exons, MITF
gives rise to various isoforms, such as MITF-A, -B, -H and M, having
different N-terminal peptides [25,29]. Only the MITF-M isoform
(MITF variant 4, NM_000248) undergoes melanocyte/melanoma–
specific transcription in response to the α-melanocyte–stimulating
hormone signaling [29], whereas other isoforms are controlled by
distinct promoters and transcribed in many tissues and cancer cell
lines [32].
We studied HERV-K transcription controlling mechanisms by
determining the initiator (Inr) sites and enhancer sequences in the
LTR. Our results indicate that an arrangement of (MITF motifs)–




Adenovirus-transformed human embryonic kidney 293 (HEK293)
cells and melanoma lines, MeWo and G361, were supplied by the
Japanese Collection of Research Bioresources (Osaka, Japan) and main-
tained with minimum essential medium supplemented with sodium
pyruvate, nonessential amino acids, antibiotics, and 10% fetal bovine
serum (FBS). SK-MEL-28 melanoma cells were from the American
Type Culture Collection. Human epidermal melanocytes from lightly
pigmented adult skin (HEMa-LP) were purchased from Invitrogen
(Carlsbad, CA), and were cultured in Medium 254 (calcium/serum–
free) with human melanocyte growth supplement (Invitrogen).
Plasmids
The HERV-K LTR sequences (GenBank AF074086.2) were am-
plified by polymerase chain reaction (PCR) from a Bac clone, RP11-
33P21 having approximately 154-kb sequences of chromosome 7. The
5′ and 3′ primers used areNheI-KLTR5-2 (5′-ccgctagctgtggggaaaagcaa-
gagagatca-3′) and BglII-KLTR3-2 (5′-gcagatctcacctgtgggtgtttctcg-
taaggt-3′). The amplified LTR sequences (nos. 1-945) were inserted
into pGL3-Basic (Promega, Madison, WI) at the NheI/BamHI sites.
pGL3-Control (Promega), in which the SV40 early promoter is linked
to the Luc gene, was used as a positive control. In vitromutagenesis was
carried out with the Gene Tailor Site–Directed Mutagenesis System
and Platinum Taq High Fidelity (Invitrogen). The MITF-M clone,
pHMI-9, was provided by Dr Shigeaki Shibahara through the RIKEN
Bioresource Center (RDB 1786). The MITF-M–encoding sequences
were excised by HindIII/XbaI digestion and recloned into pRc/CMV
(Invitrogen) at the HindIII/XbaI sites.
Luciferase Assay
Cells (105 in each well of a 24-well plate) were seeded 24 hours
before transfection. Plasmid transfection was with Effectene (Qiagen,
Hilden, Germany). Forty-eight hours after the transfection, cells were
lysed in Glo-lysis buffer (Promega) for determination of the luciferase
activity with the Steady-Glo luciferase assay system (Promega) [33]. For
induction with phorbol 12-myristate 13-acetate (PMA), transfected
cells (at 16 hours) were starved in the medium containing 0.5% FBS
for 8 hours and incubated with or without 20 ng/ml of the drug (Sigma-
Aldrich, St Louis, MO) for an additional 24 hours.
Rhesus Monkey Tissues
Tissues of rhesus monkeys, a 13-year-old female and a 6-year-old
male, were obtained immediately after killing by exsanguination
through the bilateral carotid arteries under deep anesthesia using ke-
tamine hydrochloride and sodium pentobarbital at the Primate Re-
search Institute, Kyoto University, in accordance with the guidelines
of the institute.
RNA Purification
Tissues and cultured cells were homogenized in RNAwiz (Ambion,
Austin, TX) to purify RNA. Isopropanol-precipitated RNA was fur-
ther purified with the RNeasy MinElute Cleanup system (Qiagen).
DNA fragments possibly contained in the RNA preparations were di-
gested with DNase I (Invitrogen, amplification grade) before reverse
transcription (RT)–PCR. The High-Pure RNA Isolation Kit (Roche
Diagnostics, Mannheim, Germany) was used for normal melanocytes.
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Reverse Transcription–Polymerase Chain Reaction
Semiquantitative RT-PCR was performed with the SuperScript
One-Step RT-PCR System with Platinum Taq DNA Polymerase
(Invitrogen). KP1-2 (targeting nos. 911-933, 5′-ctctcgtcccaccttacgag-
aaa-3′), KP1 (nos. 916-933, 5′-tcccaccttacgagaaa-3′), KP3 (gag, 5′-gagc-
cattaccggctctgctacat-3′), and KP7 (Rec, 5′-acaaaaccgccatcgtcatcatgg-3′)
were newly designed. KP-g3 (5′ end of gag, 5′-tttgccccattatcacccta-3′)
and KP-e1 (env, 5′-gtgacatcccgcttaccatgtgataagtg-3′) have been de-
scribed [9]. For the detection of the MITF isoforms, MITF-A-F (5′-
aaagtcaaccgctgaagagcag-3′), MITF-B-F2 (5′-gtatgcattttggttttccca-3′),
MITF-H-F (5′-atgttcatgccatgctcctt-3′), and MITF-M-F2(ATG) (5′-
atgctggaaatgctagaatataatcact-3′) were used as forward primers. Reverse
primers were MITF-b1b-R (5′-actcacgggcactctctgtt) and MITF-R2
(5′-gaatgtgtgttcatgcctgg-3′). Human 18S ribosomal RNA (rRNA) was
amplified with Hu-18S-F (5′-GTAACCCGTTGAACCCCATT-3′)
andHu-18S-R (5′-ccatccaatcggtagtagcg-3′). Rhesusmonkey 18S rRNA
was tested with Mmula-18S-F (5′-aattccgataacgaacgaga-3′) and Mmula-
18S-R (5′-atctaagggcatcacagacc-3′). These primers were synthesized
by Invitrogen.
Determination of the Transcriptional Initiation Sites
The 5′ ends of HERV-K full-length RNA were determined by the 5′
rapid amplification of complementary DNA ends (5′ RACE) system
(Invitrogen). We used a primer, KP7, targeting the env/rec/np9 region
as the gene-specific primer in the RT reaction. KP-g3 (5′-tttgccccatta-
tcacccta-3′) targeting a 5′ terminal gag region and BglII-GSP3-RACE5
(5′-ttccgagctcgctcgagcgtaccttcaccctaga-3′) targeting the leader region
were used at the PCR and nested PCR steps, respectively. Products were
digested with SpeI and BglII to be cloned into pUC19 and sequenced.
Immunofluorescence Experiments
Human adult normal tissue panels (T8234605) and human fetus tis-
sue arrays (BE01015) were was purchased fromBiochain (Hayward, CA)
and US Biomax (Rockville, MD), respectively. Immunofluorescence
staining was performed as described [34]. After the antigen retrieval
by incubation in the LAB solution (Polysciences, Warrington, PA) for
15 minutes at 60°C, cells were permeabilized and incubated with an
anti-MITF (rabbit IgG, ab20663; Abcam, Cambridge, United Kingdom)
antibody (at a dilution of 1:250) and an anti–HERV-K core (HERM-
1831-5, mouse monoclonal; Austral Biologicals, San Ramon, CA)
antibody (1:500) for 90 minutes. HERM-1831-5 represents a mouse
monoclonal antibody (clone 4D4/F7) obtained by immunization of
mice with HERV-K gag antigen (82 kDa). Tissue slides were next
incubated with secondary antibodies conjugated with Alexa Fluor
488 or 594 (Invitrogen) for 60 minutes, followed by a 10-minute
incubation with Hoechst 33342 (Sigma-Aldrich) for mild nuclear
staining. For the control experiment, the anti–HERV-K antibody
(1 μg) was neutralized by incubation with the HERV-K gag protein
(50 μg) (HERV-K CA; ProteinTech Group, Chicago, IL) in phosphate-
buffered saline (500 μl) for 18 hours at 4°C. Fluorescence images were
captured by Nikon E600 with the Digital Sight DS-Fi1 system (Nikon,
Tokyo, Japan).
Results
Differences in the HERV-K LTR Regulation between HEK293
and MeWo Cells
The LTR region (nucleotides nos. 1-945) of HERV-K (HML-2.
HOM, human endogenous MMTV-like), also referred to as ERVK6,
on chromosome 7 (GenBank AF074086.2) was amplified by PCR
from BAC clone RP11-33P21 and inserted into pGL3-Basic. This
locus has a tandem repeat of the HERV-K genome with three LTRs:
LTR-1, -2, and -3 (Figure 1A) [35]. Our clones HKLTR-1 to -5 were
∼99% identical to the reported sequences. We use the nucleotide
numbering of AF074086.2 throughout this report, in which nos. 1
and 968 corresponded to the 5′ and 3′ ends of LTR-1 [35]. On the
basis of the human genome sequence data (NT_007819.16 and
NT_079592.2) and our sequencing analyses, however, we place an A
residue at no. 796 so that nos. 793 to 780 octamer reads ′5′-AATAAA-
TA-3′ instead of ′5′-AATGAATA-3′.
In the luciferase gene (Luc) reporter assays, HKLTR-1 was three-fold
less active than the control SV40 early promoter (pGL3-control) in
human embryonic kidney HEK293 cells without the large T antigen.
The strong Luc expression in MeWo (Figure 1B, right) seemed to reflect
the high-level chromosomal HERV-K expression. PMA (20 ng/ml)
enhanced the HERV-K LTR and the SV40 promoter two-fold and
three-fold, respectively, in serum-starved HEK293 cells (Figure 1B, left).
Intriguingly, the LTR was not influenced by PMA in serum-starved
MeWo cells, whereas the SV40 promoter was 1.4-fold enhanced
(Figure 1B, right). The LTR function inMeWo cells may not be further
potentiated by protein kinase C pathway stimulation. Other HERV-K
LTR clones, HKLTR-2 to -5, were indistinguishable fromHKLTR-1 in
these and the following assays (data not shown).
Deletion analysis of the HERV-K LTR indicated that the pro-
moter activity is regulated by different regions between HEK293
and MeWo cells (Figure 1, C and D). We were not able to identify
a specific region that responded to PMA in HEK293. Most intrigu-
ingly, both Del-7 (nos. 684-945) and 7-LTR (nos. 1-704) were able
to induce Luc expression in HEK293 cells, whereas Del-7, but not
7-LTR, could exert the promoter function in MeWo. We hypothe-
sized the presence of at least two promoters, one in 7-LTR and the
other in Del-7, which are activated in different modes between the two
cell lines.
Multiple Initiation Sites in Chromosomal HERV-K LTRs
To determine the initiator (Inr) sequences in the HERV-K LTR
on the chromosomal DNA, we performed a 5′ RACE experiment
with RNA purified from MeWo and HEK293. To determine the 5′
terminus of the full-length viral RNA, we designed gene-specific prim-
ers: KP-7 (targeting rec/np9), KP-g3 (gag), and BglII-GSP3-RACE5
(5′ leader) for the RT reaction, PCR, and nested PCR, respectively (Fig-
ure 2A). Seventeen of 40 clones obtained from MeWo were derived
from the HERV-K LTR-driven viral gene transcripts (Figure 2B,
subpanel (1)). Four clones contained unrelated 50 to 80 nucleotide
sequences; the other 19 are described in the next section.
Within the HERV-K LTR-derived 5′ RACE products, we found
11 clones starting at nucleotide no. 826, four clones starting at
no. 796, and single clones starting at no. 910 or no. 918 (Figure 3A).
All of the detected initiation sites were within the Del-7 region,
supporting the Luc assay results in MeWo (Figure 1D). However,
nos. 910 (T/U residue) and 918 (C residue) were inappropriate as a
conventional initiation nucleotide and were speculated to be 5′ ends of
processed RNA. Nucleotide BLAST (Basic Local Alignment Search
Tool, National Center for Biotechnology Information) searches indi-
cated that each of the no. 826-initiated transcripts, with an exception of
clone-3, was templated by a certain HERV-K locus on chromosome 1,
6, 7, 19, or 22 on the basis of the nucleotide substitutions at a few
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positions (Figure W1B). We failed to identify the templates for the
no. 796-initiated transcript (four clones) having an A-to-T alteration at
no. 929 in the human genomic sequences (Figure W1A). Cell line–
specific chromosomal alteration and locus-specific transcriptional activa-
tion were speculated for the minor initiation at no. 796. Thus, no. 826
seemed to serve as the most potent Inr (Inr826), which was functional at
several loci on the human chromosomes. Interestingly, we found, 25 bp
upstream of Inr826, octanucleotide 5′-AATAAATA-3′ (nos. 793-800)
matching the TATA box consensus sequence TATA(A/T)A(A/T)
[36,37] (Figure 3B).
Within the 40 clones of the 5′ RACE products fromHEK293 RNA,
we identified 7 starting at no. 460, 3 starting at no. 813, and 2 start-
ing at no. 815 (Figures 3A and W2). These were also consistent with
the Luc assay result that both 7-LTR and Del-7 acted as an indepen-
dent promoter in HEK293 cells. Nucleotide no. 460 seemed to be
the major initiation site in this cell line and was tentatively termed
Inr460. We noted that all of the 5′ RACE clones starting at Inr460
shared 33 nucleotide substitutions when compared with HERV-K
(HML-2.HOM) and were derived from a locus on chromosome 3.
Detection of HERV-K–like Transcripts without a 5′ LTR
Nineteen of the 40 clones obtained from MeWo had 5′-terminal
unknown sequences preceding the 5′ leader sequences of HERV-K
(Figures 2B, subpanel (2), and W1C). We could identify the template
sequences at 7q22, which showed a 3.6-kb deletion spanning the pol
and env genes (ref: NT_007933.15 and NT_2079596). Because of
the long deletion, these transcripts may have been more efficiently re-
verse transcribed and amplified in the 5′ RACE experiment than the
full-length HERV-K messenger RNA (mRNA).
Requirement of the Inr Sequences for the LTR Function
To test whether the major Inr sites (Inr460 and Inr826) and the
TATA box-like sequences (793TATA) are necessary for the LTR
Figure 1. Detection of the promoter function in cloned HERV-K LTR. (A) The HERV-K locus (HML-2.HOM, ERVK6) on chromosome 7. A
tandem repeat of the LTR-gag-pro-pol-env-rec/np9-LTR structure containing LTR-1, -2, and -3 are illustrated as described [35]. The forward
and reverse primers used for the LTR sequence amplification are indicated by magenta and black arrows, respectively, at the positions of
their target sequences. (B) Luciferase (luc) gene reporter assay with HKLTR-1-Luc in HEK293 and MeWo cells. The pGL3-control plasmid
containing the SV40 early promoter (SV40) and pGL3-Basic without a promoter (Basic) were examined as the positive and negative controls
of the experiments. Luciferase activity was determined after stimulation with (+) or without (−) PMA (20 ng/ml) in serum reduced (0.5%)
medium. Measurements (mean ± SD) are presented in relation to the enzyme activity (=1) obtained by pGL3-Basic. Experiments were
carried out in triplicate two times (**P < .01 vs Basic). (C) Deletion mutants examined. Nucleotide numbers (#) contained in each plasmid
are indicated. (D) Luc assay with the cloned HERV-K LTR and its deletion mutants. Luciferase activity in transfected HEK293 cells was de-
termined after stimulation with (+) or without (−) PMA (20 ng/ml) in serum-reduced (0.5%) medium. Luciferase activities in MeWo cells
incubated with 10% FBS were analyzed. Results (mean ± SD) are shown in relative light units (RLUs). Statistical significance: **P< .01 and
*P < .05 versus HKLTR (without PMA stimulation).
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function, we constructed mutants termed HKLTR-460m, -826m,
and 793TATAm (Figure 3B). In MeWo cells, the 460m mutation
even increased the luciferase activity 1.4-fold (Figure 3C ), suggesting
the possibility that no. 460 is involved in the mechanism to render
7-LTR inactive in MeWo (Figure 1D). The 793TATAm and 826m
mutations decreased the Luc expression by 97% and 88%, respec-
tively (Figure 3C ), indicating that both 793TATA and Inr826 play
an essential role in the cloned LTR.
Unlike the result in MeWo, luciferase activity produced from
HKLTR-460m was 15% decreased in HEK293 (Figure 3C). Although
Inr826-initiated transcription was not detected by 5′ RACE, Luc
expression by 793TATAm and 826m were decreased 60% and 30%,
respectively. Thus, 793TATA and Inr826 were also vital in HEK293.
Inr460 seemed to contribute to the LTR function in HEK293, but
less significantly. The predominant appearance of the Inr460-initiated
transcript (Figure 3A) may have caused by biased Inr usage at the
unique locus (Figure W2A) in the nonproducer cell line.
Activation of the Cloned HERV-K LTR by MITF-M
Because HERV-K is efficiently expressed in melanomas and terato-
carcinomas, transcription regulatory factor(s) governing the pigmented
tissue development could be considered as a potential HERV-K in-
ducer(s). MITF, the MITF-M isoform in particular, is a melanocytic
master transcription factor and an oncogene of melanoma [38–40].
Nucleotide sequences corresponding to E-box and related sequences
including CACATG, CATGTG, and CATATG serve as the core tar-
get sites of MITF to induce gene expression [25]. Intriguingly, three
hexanucleotides resembling the MITF binding core motifs were de-
tected upstream of 793TATA within the Del-7 region (Figure 4A):
MITF-1 (CACATC starting at no. 757, with one nucleotide mismatch
Figure 2. Summary of the 5′ RACE experiments. (A) Strategy for determination of the 5′ end of the viral RNA. HERV-K full-length and spliced
RNAs are schematically shown with the gag, PR, pol, env, and rec/np9 genes (top). Experimental processes are illustrated with gene specific
primers. (B) Products detected in the experiments. (1) Detection of the transcriptional start points in HERV-K LTR. Twenty-one of 50 clones
contained a 3′ terminal region of the 5′ LTR followed by the leader sequences. (2) Expression of a HERV-K-like element rearranged by the
loss of 5′ LTR and a 3.6-kb deletion spanning pol and env. The transcripts without a LTR sequence were aligned with the segmented HERV-K
locus at 7q22. Twenty-four of fifty 5′ RACE clones contained this structure.
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underlined), MITF-2 (CTTGTG at no. 744), and MITF-3 (CACATG
at no. 688). An additional motif, MITF-4 (CATATG at no. 832),
was found six bases downstream of Inr826 (Figure 5A). We inserted
one or two nucleotide mutations into each MITF motif to gener-
ate mutants termed MITF-1m (CggATG), MITF-2m (CggGTG),
MITF-3m (CggATC), and MITF-4m (CggATG). Results of the Luc
assays indicated that MITF-1, -2, and -3, but not MITF-4, contrib-
ute significantly to the promoter function of the LTR in MeWo cells
(Figure 5C).
The basal-level Luc expression in HEK293 was not greatly altered
by any of the MITF motif mutations (Figure 5D). When HKLTR-
luc was cotransfected with a CMV promoter–driven MITF–M ex-
pression vector, a substantial increase in Luc expression was observed
(∼140-fold increase in the luciferase activity). This strong transactiva-
tion by MITF-M was cancelled in the MITF-1m, MITF-2m, and
MITF-3m mutants, but not in MITF-4m. In Western blot analysis,
the MITF-M protein (419 amino acids long) appeared as a minor
band of ∼45 kDa in MITF-M–transfected HEK293 (293/MITF-M)
cells as well as in MeWo (Figure 5B). In contrast, HEK293 cells trans-
fected with the control vector (293/vec) lacked this protein. The Del-7
region (nos. 684-945) as well as the entire LTR clone exhibited a dose-
dependent response to MITF-M in HEK293, whereas 7-LTR was
insensitive to MITF-M (Figure W3). Thus, forced expression of
MITF-M inHEK293 caused strong HERV-K LTR activation depend-
ing on the MITF-1, -2, and -3 motifs.
Induction of Chromosomal HERV-K by MITF-M
We analyzed MITF gene expression in HEK293 and MeWo by
RT-PCR with isoform-specific primers (Figure 6, A and C). MITF-A
and MITF-B were transcribed equally in these cell lines. MITF-H was
expressed more efficiently in HEK293 than in MeWo. MITF-M was
clearly expressed in MeWo but not in HEK293. Total MITF ex-
pression did not significantly differ between the cell lines as analyzed
with the pan-MITF-2 primer pairs. HEK293 cells transfected with
the MITF-M expression vector showed a substantial increase in the
MITF-MmRNA without an alteration in other isoforms. These results
were consistent with the Western blot analysis results, in which two
dominant MITF bands appeared equally in the two cell lines, whereas
MITF-M was detectable in MeWo, but not in HEK293 (Figure 5D)
as observed in various cancer cell lines [32].
We next examined these cells for production of full-length HERV-K
mRNA encoding gag-pol, spliced env mRNA, and doubly spliced rec/
np9 mRNA (Figure 6, B and D). Forward primers (KP1, KP1-2) were
designed to hybridize sequences downstream of Inr826. Consistent
with the previous report [9], high-level expression of the spliced env
mRNA and the doubly spliced rec mRNA was evident in MeWo,
whereas neither the env nor the rec RT-PCR product was detectable
in HEK293. The gag-encoding viral RNA was found in HEK293 at
a lower level, whereas it was increased three-fold in MeWo. Interest-
ingly, MITF-M–transfected HEK293 cells significantly enhanced the
env and recmRNA synthesis. The gag-encoding RNA was also increased
Figure 3.Multiple Inrs detected in the HERV-K LTR. (A) Results of the 5′ RACE analyses. Positions of the 5′ ends (rectangular arrows) of
the HERV-K mRNA from MeWo and HEK293 cells are schematically shown. Number of detected clones (from among the 40 clones) is in
brackets. (B) Mutation of Inr460, 793TATA, and Inr826. The original nucleotide sequences and mutated sequences in 460m, 793TATAm,
and 826m are indicated. Major and minor initiation sites are indicated by filled and open rectangular arrows, respectively. The 793TATA
sequences, 5′-TATA(T/A)A(A/T)(A/G)-3′, corresponding to the TATA box consensus are boxed. (C) Luc assay with HKLTR-1 and the Inr
mutants in HEK293 and MeWo cells. Luciferase activity (mean ± SD) is shown in RLUs. Experiments were performed in triplicate two
times. Statistical significance: **P < .01 and *P < .05 versus HKLTR-1.
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two-fold by MITF-M. Thus, forced expression of MITF-M caused
chromosomal HERV-K activation in HEK293.
Elements Conserved between the Human and Rhesus-type
HERV-K LTRs
We detected 113 LTR copies with 95% or higher sequence identity
to the HERV-K LTR (HML-2.HOM) in the human genomic se-
quences (Table W1). MITF-1, MITF-2, MITF-3, 793TATA, and
Inr826 were conserved in 108 LTRs, 102 of which had an equivalent
MITF motif (5′CACGTG3′) in place of MITF-3 (5′CACATG3′).
Inr460 was also conserved in 86 LTRs but inactivated by a nucleotide
substitution (A-to-C) in 27 LTRs.
In the rhesus monkey genome, we detected 33 LTR-like ele-
ments with 80% or higher nucleotide identity to the HERV-K LTR
(Table W2). The GGA(Inr460)ATGC sequence was disrupted in 12
LTRs but existed in other LTRs in a modified form (AGAAGGC),
which may possibly retain the Inr function. Twenty-seven LTRs
had 793TATA, whereas four showed a single nucleotide substitu-
tion in the octanucleotide. None of the rhesus LTRs had an Inr826-
like sequence. However, a heptanucleotide matching the consensus
of Inr, PyPyA+1N(T/A)PyPy [41,42], was inserted at a position
corresponding to Inr826 in 13 LTRs. Three MITF motifs were
contained in three LTRs, two MITF motifs in six LTRs, and only
one MITF motif in 23 LTRs. The rhesus version of HERV-K could
possibly be controlled by mechanisms similar to those found in
human HERV-K.
Detection of MITF and HERV-K Expression in RPE
Rhesus monkey tissues were examined for MITF and rhesus-
type HERV-K expression by RT-PCR (Figure 7). The human MITF
primer pairs shown previously (Figure 6A) were also used in this ex-
periment because the MITF isoform sequences were identical between
the two species. The primer pair (KP-1/KP-g3) targeting the sequences
shared by the human and rhesus-type HERV-K was used to detect
the gag-encoding transcript. Rhesus 18S ribosomal RNA was amplified
for normalization.
The MITF-A mRNA level was similarly high in the kidney, brain,
seminal vesicle, testis, and retina but was undetectable in the mam-
mary gland and ovary under the assay conditions. Enhanced MITF-M
expression was observed not only in the retina but also in the seminal
vesicle. The spleen and brain seemed to produce MITF-M mRNA less
predominantly. TotalMITF expression was most intense in the kidney,
retina, and seminal vesicle but very weak in the mammary gland and
ovary. TheMITF expression profiles in the rhesus tissues were consistent
with the expression pattern extracted from the human EST database
and conventional analyses [32], although the seminal vesicle has not been
examined previously.
Rhesus-type HERV-K expression was most active in the pigmented
tissues, retina, and seminal vesicle [43], supporting the observation
that the rhesus-type LTRs also contain MITF motifs (Table W2). Less
predominant but correlated expression of HERV-K and MITF-M
were detected in the spleen and brain. Other tissues including the testis
and kidney showed a level of HERV-K mRNA, which was not corre-
lated to MITF-M mRNA.
Figure 4. Transcriptional regulatory elements in HERV-K LTR. (A) Nucleotide nos. 1 to 968 of HERV-K LTR are shown according to the
numbering in GenBank AF074086.2 (HML-2.HOM). Rectangular arrays indicate the major initiation sites (Inr460 and Inr826) determined
by 5′ RACE. MITF-M–responsive sequences (MITF-1, -2, and -3) and 793TATA are highlighted (magenta). MITF-4 is underlined. A list of
MITF binding core sequences used in the known MITF-induced genes is provided in reference [25]. The first nucleotide (no. 684) of the
Del-7 region is marked by an arrowhead. (B) Proposed framework of HERV-K LTR. Inr826 defines the U3-R junction. Relative positions of
Inr826, 793TATA, and the enhancer region formed by MITF-1, -2, and -3 are indicated. Inr460 is also indicated.
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We performed an immunofluorescence analysis with a human fetus
tissue array (Figure 8). Because MITF-M–specific antibody was not
available, an antibody (ab20663) recognizing the C-terminal domain
shared by all of the MITF isoforms was used in combination with an
anti–HERV-K core antibody (HERM-1831). In the retina/choroid
sections, RPE displayed a strong label by MITF (red, Figure 8A,
column a) as reported [44]. The anti–HERV-K antibody also stained
RPE strongly ( green). The choroid region was poorly reactive with these
antibodies. In the control experiment, the anti–HERV-K antibody
neutralized with the HERV-K gag peptide failed to stain the RPE
(Figure 8A, column b). Other tissues including the liver (Figure 8B)
were moderately or poorly reactive with the anti-MITF and anti–
HERV-K antibodies. Immunofluorescence images of the seminal vesi-
cle sections were not informative because of an intense autofluorescence
of the lipofuscin granules in the epithelium [43] (data not shown).
MITF-M and HERV-K Expression in Normal and
Transformed Melanocytes
Three malignant melanoma lines, G361, SK-MEL-28, and
MeWo, were compared with normal human epidermal melanocytes
for the levels of MITF and HERV-K expression by semiquantitative
RT-PCR (Figure 9). The levels of total MITF isoforms and MITF-M
were constant in the melanoma lines and normal melanocytes. How-
ever, G361, SK-MEL-28, and MeWo showed different levels of the
gag (full-length) (1:4:2.7), env (1:3:1.4), and rec (1:2:1.5) mRNAs.
In normal melanocytes cultured in the serum/calcium–free medium,
the amounts of HERV-K mRNAs were only 3% to 10% of those in
MeWo. When exposed to 1% FBS for 9 hours, the melanocyte cul-
ture increased the gag and rec mRNAs three-fold or higher without a
further increase in MITF-M mRNA. Thus, the level of HERV-K
transcription was not directly correlated with that ofMITF-M in mela-
noma cells and melanocytes, consistent with the requirement of post-
translational modifications including Ser73 phosphorylation by Erk2
for functional activation of MITF-M [25,28,45,46]. MITF-M was
thought to determine the melanocyte/melanoma lineage specificity of
HERV-K expression.
Discussion
We studied transcriptional activation of the HERV-K LTR in
melanoma cells. The three MITF binding motifs, the TATA box
(793TATA), and the major Inr site (Inr826) seemed to serve as a
potent enhancer/promoter unit. In nonmelanoma HEK293 cells,
both the cloned LTR function and chromosomal HERV-K expres-
sion were strongly activated by forced expression MITF-M, an RPE/
melanocyte–specific isoform of MITF. Requirement of MITF-M for
the LTR activation seemed to explain the lineage-specific expression
of HERV-K.
Endogenous retrovirus expression may undergo varied pathways
of transcriptional regulation depending on cell lineages and cellular
contexts as reported previously [24,47]. Presence of the multiple Inr
sites may reflect the complexity of cellular transcription regulatory
mechanisms and the flexibility of retroviral LTRs, allowing ubiquitous
Figure 5. MITF-binding motifs essential for the HERV-K LTR activation by MITF-M. (A) (Top) An array of the MITF-binding motifs (MITF-1, -2,
-3, and -4) is graphically shown in relation to the initiation sites (Inr826). (Bottom) Mutated nucleotides in MITF-m1, -m2, -m3, and -m4 are
indicated in lower case. (B) Detection of MITF-M by Western blot analysis. Lysates of HEK293 (293), MeWo, and HEK293 transfected
with MITF-M (293/MITF-M) were probed with an anti-MITF antibody. Molecular masses (kDa) and positions of the biotinylated protein stan-
dards (BS) and prestained color standards (CS) are indicated. MITF-A (520 amino acid residues, 59 kDa; GenBank BAA32288.1; National
Center for Biotechnology Information Reference Sequence: NP_937802.1) and 44-kDa MITF-M (419 residues; NM_000248.3) are indicated
on the basis of their molecular masses and the RT-PCR analyses shown in Figure 6. (C) Luc assay with the MITF motif mutants in MeWo.
Experiments were performed in triplicate two times. Luciferase activity (mean± SD) is shown in RLUs. Statistical significance: **P< .01 and
*P < .05 versus HKLTR-1. (D) Transactivation of the HERV-K LTR by MITF-M in HEK293 cells. HKLTR-1 and the mutants were transfected in
combination with a CMV promoter–driven MITF-M expression vector (+) or with the empty vector (−) at a weight ratio of 1:1.
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Figure 6. Induction of chromosomal HERV-K expression by forced expression of MITF-M. (A) MITF variant mRNAs with 5′ terminal isoform-
specific exons are shown in ribbon-like structures. Exons 3 to 9 were compressed in the finned box. Positions of the forward and re-
verse primers are indicated by arrows. The pan-MITF-2 primer pairs were designed to detect exon 2 shared by the known MITF variants.
(B) Structure of the gag-encoding full-length HERV-K RNA and spliced mRNAs encoding env and rec/np9. Splicing events are indicated by
dotted lines. Arrows show positions of the primers used in RT-PCR. (C) Results of the RT-PCR experiments for MITF mRNAs. HEK293 (293),
MeWo, and MITF-M transfected HEK293 (293/MITF-M) were analyzed. Position of the 500-bp marker and sizes (in bp) of the amplified
products are indicated in parentheses. The control reaction for 18S ribosomal RNA is also shown. (D) RT-PCR analyzing the gag, env, and
rec mRNAs. Primers applied are shown in brackets.
Figure 7. Expression of the older version HERV-K and MITF in rhesus monkey tissues. Rhesus monkey (Macaca mulatta) tissues including
the mammary gland (Mam. gland) and seminal vesicle (Sem. vesicle) were examined by RT-PCR for expression of the rhesus HERV-K–like
elements and the MITF variants. Macaca (Mac) 18S rRNA was also analyzed for standardization of the RNA amounts.
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basal-level expression [1]. By focusing on the high-level expression of
HERV-K in melanoma, we identified MITF-M as an inducer of the
HERV-K LTR. The arrangement of MITF binding motifs (MITF-1,
-2, and -3), 793TATA, and Inr826 (Figure 4B) may compose a typical
enhancer/promoter structure for RNA polymerase II as found in all
of the retroviral LTRs studied so far [48]. Because the 5′ end of the
R region is defined by the Inr, the U3 region the HERV-K LTR is
thought to span from no. 1 to no. 825. This region is long enough
to recruit other regulatory proteins, which may cooperate with the
initiation factors associated with the core sequences in melanomas.
In normal melanocytes under the calcium/serum–free conditions,
MITF-M was highly expressed without inducing HERV-K transcription.
Interestingly, serum stimulation enhanced HERV-K transcription in
these cells. The transactivating function of MITF-M is known to be
enhanced on Ser73 phosphorylation by MAP kinase in response to
c-kit [28]. Varied signaling molecules that control MITF-M have been
reported [25,45,46]. Melanocytes may gain the constitutive MITF-M–
activating functions during the malignant transformation. HEK293
cells would be able to activate it but only if it is synthesized in the cells.
Our results do not rule out the possibility that other MITF isoforms
are involved in HERV-K LTR activation by a direct or indirect inter-
action with MITF-M. Moreover, the TFE family proteins including
TFE3, TFEb, and TFE are closely related to the MITF proteins and also
interact with the canonical E-box motif, CA(C/T)GTG, and related
sequences [29,49]. MITF and melanocyte-specific genes are activated
in breast cancers [50], which might contribute to the HERV-K expres-
sion in the cell type [21,51].
Retroviruses trigger oncogenesis by varied mechanisms including 1)
virus-encoded oncogene(s) and 2) promoter/enhancer insertion up-
stream of tumor-inducing genes [48]. The rec/np9 genes of HERV-K
are expressed through double splicing as found in the tax gene, an
oncogene of human T-cell leukemia virus [48]. The Rec/Np9 pro-
teins also seemed to exert an oncogenic function through the inter-
action with cellular zinc-finger proteins [11–13]. In addition, MITF-M
activates not only the 5′ LTR that controls the viral gene expression
but also the 3′ LTR, which could activate cell growth/survival genes
downstream of the HERV-K loci. Melanoma metastasis involves varied
mechanisms including integrin α4 expression [52], chromosomal insta-
bility [53], microRNA expression [54], and loss of AP-2 [55]. HERV-K
may possibly influence the processes of melanoma progression through
the MITF-M–mediated LTR activation and/or Rec/Np9 production.
Recent studies on HERV-K also support this hypothesis [18–20].
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Figure 9. Expression of MITF and HERV-K mRNAs in normal and
transformed melanocytes. Semiquantitative RT-PCRwas performed
with RNA purified from normal human melanocytes (NHM/FBS–
free) and melanoma lines, G361, SK-MEL-28, and MeWo. NHM
cultured with 1% FBS for 9 hours (NHM/1% FBS) was also analyzed.
MITF-M, total MITF, and HERV-K mRNAs (gag, env, and rec), and
18S rRNA were amplified with primers shown in Figure 6.
Figure 8. Detection of MITF and HERV-K in human RPE. A normal fetus tissue array (BE01015) was labeled for the MITF (red) and HERV-K
core (green) proteins. Unblocked (column a) and blocked (column b) anti–HERV-K core (HERM-1831) IgG was used in combination with
anti-MITF IgG (ab20663). Uncropped images of the retina/choroid and liver sections are shown. RPE (arrow) and the choroid (Ch) are
indicated. Mild nuclear staining with Hoechst 33342 is also shown. Scale bar, 50 μm.
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Figure W1. Nucleotide sequences of the 5′ RACE clones obtained from MeWo cells. (A) Clones indicating transcriptional initiation at
nucleotide no. 796 are aligned with the LTR-leader sequences (HERVK-LTR-Leader) of HML-2.HOM (GenBank AF074086.2). Nucleotides
identical to the HERVK-LTR-leader sequences are in blue, and mismatches in magenta. The 3′ end of the LTR is marked by a line.
(B) Clones corresponding to the transcripts starting at no. 826 are shown. The first 6 clones of 11 are shown. (C) Alignment of the
5′ RACE products indicating transcriptional initiation by a non-LTR promoter at 7q22. Corresponding chromosomal sequences
(NW_001839071) are also aligned. Regions unrelated to HERV-K are in magenta.
Figure W2. Nucleotide sequences of the 5′ RACE products obtained from HEK293 cells. (A) The 5′ RACE clones starting at no. 460 are
aligned with the HERV-K LTR-leader sequences. These clones showed 44 nucleotide mismatches (only 92% sequence identity) compared
with the 570 nucleotides of HML-2.HOM. A BLAST search identified the template sequences at a unique locus on chromosome 3
(NT_005612). Nucleotides identical to the HERVK-LTR-leader sequences (GenBank AF074086.2) are in blue and mismatches are in magenta.
The 3′ end of the LTR is marked by a line. (B) Clones starting at no. 813 or no. 815 are aligned. They show approximately 99% sequence identity
to the HERV-K LTR-Leader and thought to represent the transcripts from HML-2.HOM and related HERV-K loci.
Figure W3. Transactivation of HERV-K LTR by MITF-M. Luc expres-
sion assay with HKLTR-1, Del-7, and 7-LTR in combination with
the MITF-M expression vector. Relative luciferase activity (RLA)
(mean ± SD) is presented in relation to the control assay (1.00) with
HKLTR-1 and the empty vector (Vec). The ratio (0.5, 1) of the ac-
tivator plasmid amount to the Luc plasmid amount is given in paren-
theses. Experiments were performed two times in triplicate.
Table W1. Human Genomic LTRs with Less Than 95% Sequence Identity to the HERV-K LTR (HML-2.HOM).
Table W1. (continued ).
Table W1. (continued ).
Sequences identical to the corresponding positions of the HERV-K LTR (HML-2.HOM) are in black. Altered sequences that seemed
to preserve the proposed functions are in blue. Nucleotide substitutions expected to disrupt the function are in red.
Table W2. Rhesus Monkey (Macaca mulatta) LTRs with Less Than 80% Sequence Identity to the Human-type HERV-K LTR.
Sequences identical to the corresponding positions of the HERV-K LTR (HML-2.HOM) are in black. Altered sequences that seemed to preserve the proposed
functions are in blue. Nucleotide substitutions expected to disrupt the function are in red.
